BioMarin Reaffirms Long-Term Guidance And Outlook Previously Provided At Investor Day On September 4, 2024, Targeting ~$4B In Total Revenues In 2027; 40% Non-GAAP Operating Margin Starting In 2026 And Growing To The Low- To Mid-40% Range Over Time
Portfolio Pulse from Benzinga Newsdesk
BioMarin has reaffirmed its long-term financial guidance, targeting $4 billion in revenues by 2027 and a 40% non-GAAP operating margin starting in 2026. The company also projects over $1.25 billion in operating cash flow annually from 2027 and a mid-teen CAGR for revenues through 2034.
October 29, 2024 | 8:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioMarin reaffirms its long-term financial targets, including $4 billion in revenues by 2027 and a 40% operating margin starting in 2026, indicating strong growth prospects.
BioMarin's reaffirmation of its financial targets suggests confidence in its growth strategy, likely boosting investor sentiment and positively impacting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100